A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.
Active Trade on Messaging Platforms
Additionally, a flourishing market exists on Telegram, where groups with numerous of members share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Express Concerns
However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could result in users administering products of uncertain source.
Some professionals said the popularity for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.
Some influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Material Removal
Based on TikTok, the service has removed problematic material and prohibited related hashtags and search suggestions. The company said it was dedicated to keeping the service safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Operations
Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, glowing reviews and detailed instructions for mixing or injecting at residence.
Within minutes of entering one community, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.
Item Information and Pricing
Inside these communities, posts display black plastic parcels with postal service stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20 milligrams. When asked how much time a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service stated it regularly monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of an online medical service connected the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake injections are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.
Her team has previously seen individuals injured by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to possibly significant medical dangers”.
